A team at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) has developed a comprehensive set of innovative genetic tools and mouse lines, called iFlpMosaics, designed to enhance the study of gene function and its implications in health and disease.
Shionogi secures license for Maze’s Pompe disease treatment
Phase I clinical trial results indicated that MZE001 could become the first oral therapy option for Pompe disease. Credit: murat photographer / Shutterstock.com. Shionogi has